We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Diatron MI Plc

Develops, manufactures and markets hematology analyzers, clinical chemistry analyzers, and associated reagents for hu... read more Featured Products: More products

Download Mobile App





Diatron Exhibits Advanced Hematology and Clinical Chemistry Analyzers at MEDICA 2022

By LabMedica International staff writers
Posted on 16 Nov 2022
Print article
Image: Diatron has been present at MEDICA for the past 15 years at the same booth location (Photo courtesy of Diatron)
Image: Diatron has been present at MEDICA for the past 15 years at the same booth location (Photo courtesy of Diatron)

Diatron (Budapest, Hungary) is exhibiting its advanced hematology analyzers and clinical chemistry analyzers, along with associated reagents at the 2022 edition of MEDICA, the world's largest trade fair for medical technology, being held from 14 to 17 November in Düsseldorf, Germany.

At MEDICA 2022, Diatron is exhibiting the KleeYa open, flexible CLIA platform which provides a unique approach to the use of different bead-based CLIA technologies, offering superior assay performance and providing ease of use with cost containment. Diatron’s KleeYa, a highly flexible, fast and sensitive random access CLIA platform for immunoassay menu, handles tests from various providers and is able to combine a wide variety of assay designs.

Also on display at the Diatron booth at MEDICA is the company’s new P780 clinical chemistry analyzer alongside the Aquila 3-part differential hematology analyzer. The Diatron Aquila is an innovative and revolutionary hematology analyzer that can be used in any testing location and application where high quality CBC results are desired. The Diatron Aquila can be used to perform complete CBC with human blood, collected in either standard EDTA collection tubes (Vacutainer type) or with micro sampling tubes. It delivers accurate results with regular and micro-sampling collection tubes with only 20 μl blood required and results in less than one minute. The QC menu offers the user the opportunity to use secondary QC limits for all parameters providing the extended QC option. The Diatron Aquila featuring the company’s latest technology offers an optimal testing solution for both experienced and inexperienced users and practices that require a high quality hematology analyzer.

Related Links:
Diatron 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.